AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Lack of Response to the Adderall Shortage and the Monopoly Power in the Pharmaceutical Industry
This chapter discusses the lack of response from Congress and the Biden administration regarding the Adderall shortage and the monopolistic behavior of major distributors in the pharmaceutical industry. It explores the stigma surrounding Adderall, the connection between prescription drug abuse and the opioid crisis, and the impact of monopolistic behavior on the availability of Adderall.